C5 and amyotrophic lateral sclerosis: This is in line with C5a protein levels at mid-symptomatic stage in the spinal cord and TA muscle of hSOD1G93A mice [11], suggesting that enhanced C5a-C5aR1 signalling may affect disease progression of ALS, similar to what has been found in hSOD1G93A mice.